1 – 25 of 25
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Economic Burden of Parkinson’s Disease : A Multinational, Real-World, Cost-of-Illness Study
2024) In Drugs - Real World Outcomes(
- Contribution to journal › Article
- 2022
-
Mark
Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease?
(
- Contribution to journal › Scientific review
-
Mark
Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain : rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial
(
- Contribution to journal › Article
-
Mark
Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep : Results from a Meta-Analysis with 24-Month Follow-Up
(
- Contribution to journal › Scientific review
-
Mark
Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease : A Systematic Review and Bayesian Network Meta-analysis
(
- Contribution to journal › Scientific review
-
Mark
Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries
(
- Contribution to journal › Article
- 2021
-
Mark
Cost-Effectiveness of Device-Aided Therapies in Parkinson's Disease : A Structured Review
(
- Contribution to journal › Scientific review
-
Mark
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease : A Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
Digital health technology for non-motor symptoms in people with Parkinson's disease : Futile or future?
(
- Contribution to journal › Scientific review
-
Mark
Advance Care Planning and Care Coordination for People With Parkinson's Disease and Their Family Caregivers—Study Protocol for a Multicentre, Randomized Controlled Trial
(
- Contribution to journal › Article
- 2018
-
Mark
Continuous drug delivery aiming continuous dopaminergic stimulation in Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson's disease
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Levodopa-carbidopa intestinal gel in advanced Parkinson's : Final results of the GLORIA registry
(
- Contribution to journal › Article
- 2016
-
Mark
A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short- and long-acting dopamine agonists
(
- Contribution to journal › Article
- 2015
-
Mark
Intraindividual Variability of Nonmotor Fluctuations in Advanced Parkinson's Disease.
(
- Contribution to journal › Article
-
Mark
Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS)
(
- Contribution to journal › Article
-
Mark
King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation.
(
- Contribution to journal › Article
-
Mark
The burden of non-motor symptoms in Parkinson's disease using a self-completed non-motor questionnaire: A simple grading system.
(
- Contribution to journal › Article
-
Mark
EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease - Clinical practice recommendations
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Characterizing motor and non-motor aspects of early-morning off periods in Parkinson's disease: An international multicenter study.
(
- Contribution to journal › Article
- 2013
-
Mark
Nonmotor fluctuations in Parkinson disease: Severity and correlation with motor complications.
(
- Contribution to journal › Article
- 2012
-
Mark
Intrajejunal Levodopa Versus Conventional Therapy in Parkinson Disease: Motor and Nonmotor Effects.
(
- Contribution to journal › Article
- 2011
-
Mark
Parkinson's disease: The non-motor issues
(
- Contribution to journal › Scientific review
- 2010
-
Mark
Non-motor Symptoms Questionnaire and Scale for Parkinson's disease
(
- Contribution to journal › Article